Trial Profile
Phase II proof-of-concept trial of sustained-release, intra-articular triamcinolone [FX 006] in active military and medically retired veterans with post-traumatic osteoarthritis of the knee.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 01 May 2015
Price :
$35
*
At a glance
- Drugs Triamcinolone (Primary) ; Triamcinolone
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 01 May 2015 New trial record